The prevalence and predictors of using herbal medicines among Iranian cancer patients.

Autor: Bazrafshani MS; Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran., Khandani BK; Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: B_kalantari@kmu.ac.ir., Pardakhty A; Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran., Tajadini H; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran., Pour Afshar RM; Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran., Moazed V; Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran., Nemati A; Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran., Nasiri N; Department of Public Health, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran., Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Jazyk: angličtina
Zdroj: Complementary therapies in clinical practice [Complement Ther Clin Pract] 2019 May; Vol. 35, pp. 368-373. Date of Electronic Publication: 2019 Mar 13.
DOI: 10.1016/j.ctcp.2019.03.009
Abstrakt: Background: and Purpose: Using of herbal medicines is common for cancer treatment. The aim of this study was to determine the prevalence, reasons, and predicting factors for the use of herbal medicines by Iranian cancer patients.
Materials and Methods: We conducted this cross-sectional study on 315 cancer patients through face-to-face interview in Kerman, Southeast of Iran, 2017.
Results: In total, 267 (84.1%) patients used at least one herbal medicine during chemotherapy courses, while only 42 (16.1%) patients discussed the use of herbal medicines with physicians. Living in urban regions (OR, 2.56; 95% CI, 1.30-5.05; P<0.0001) and the experience of constipation and diarrhea (OR, 2.11; 95% CI, 1.09-4.05; P = 0.02) were determined as some predicting factors for the use of herbal medicines.
Conclusion: Our findings indicate that as herbal medicines are common among cancer patients and their use is often overlooked, physicians should pay particular attention to herbal medicines during chemotherapy.
(Copyright © 2019. Published by Elsevier Ltd.)
Databáze: MEDLINE
Externí odkaz: